Lithuania's health ministry. It wrote the National Cancer Prevention and Control Programme 2014 to 2025 and its 2023 to 2025 implementation plan, and since July 2025 it controls the Cancer Registry's information system.
The Ministry of Health is responsible for Lithuania's National Cancer Prevention and Control Programme 2014 to 2025, which the OECD and European Commission's Country Cancer Profile 2025 describes as broadly aligned with Europe's Beating Cancer Plan: it covers risk factors, the organisation of screening, the co-ordination of cancer care, rehabilitation and psychological support, and paediatric cancer. On 16 January 2023 an Implementation Measures Plan for 2023 to 2025 was adopted, and the profile reports that a programme for 2026 to 2030 was being prepared by the Monitoring Council for the Organisation of Oncological Care and the Ministry's Specialised Healthcare Division. The coordinates are an approximate Vilnius city point.
The profile records that in 2017 Lithuania set national waiting-time targets for cancer care, among them 14 days from diagnosis to the start of treatment, and that from May 2023 a Green Corridor model with oncology care managers was introduced to meet them. The Ministry announced a move to a more population-based approach to screening, with a GP referral no longer required from 1 January 2025. The National Cancer Institute's Cancer Registry page states that the regulations of the registry's information system were approved in July 2025 with the Ministry named as the system's controller.
The Ministry's own site, sam.lrv.lt, answered a plain request with a bot challenge on 11 November 2026 and was not read for this record.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-11-19.
Matched to Ministry of Health of the Republic of Lithuania, including child institutions. 1 works · 98 citations · 100% open access · 0% clinical trials · 0% reviews.
| Work | Journal | Year | Citations |
|---|---|---|---|
| CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs 10.1038/s41591-023-02315-6 · open access | Nature Medicine | 2023 | 98 |
The fall in deaths is consistent with mammography and PSA testing arriving, lagging up to ten years, but the screening programmes are not shown to have driven it; better early detection and timely treatment are still needed.
Lithuania has offered PSA testing through a national programme since 2006; this is an account, from the National Cancer Institute's cancer epidemiology laboratory, of what the programme did in its first decade.
In its first years the programme did not by itself shift breast cancers to earlier stages; awareness and better diagnosis may explain the trends.
Shares Klaipėda University Hospital, National Cancer Institute, Lithuania, Lithuanian Cancer Registry.
Shares Cancer registries and population surveillance, Cervical cancer, Breast cancer (all types), Prostate cancer.
Shares Cancer registries and population surveillance, Cervical cancer, Breast cancer (all types), Prostate cancer.
Shares Cancer registries and population surveillance, Cervical cancer, Breast cancer (all types), Prostate cancer.
Shares Cancer registries and population surveillance, Breast cancer (all types), Prostate cancer, Colorectal cancer.
Shares Cancer registries and population surveillance, Cervical cancer, Breast cancer (all types), Prostate cancer.
Shares Cancer registries and population surveillance, Breast cancer (all types), Prostate cancer, Colorectal cancer.
Shares Cancer registries and population surveillance, Breast cancer (all types), Prostate cancer, Colorectal cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/